News
There's a strong case that healthcare is the most important sector in the stock market. Investors stand to benefit as ...
But the surge in Chinese pharma is still ringing alarm bells. “China’s rise in biotech is a threat to the United States,” ...
Three Fool.com contributors have identified no-brainer stocks to buy for under $100 right now. Here's why they picked two big ...
There's nothing like a top-level management departure to get investors worried about a publicly traded company. Investors in ...
Frost & Sullivan celebrates companies for their outstanding achievements at the Frost & Sullivan Best Practices Awards Gala ...
Managers and executives are among the highest-paid professionals in France, regardless of industry. But only five positions ...
Proposed cuts will have “a catastrophic effect on the advancement of biomedical and biotechnology capabilities in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results